- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for per
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q1 2024
ACXP stock results show that Acurx Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
HOTH Stock Earnings: Hoth Therapeutics Misses EPS for Q1 2024
HOTH stock results show that Hoth Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
ADIL Stock Earnings: Adial Pharmaceuticals Misses EPS for Q1 2024
ADIL stock results show that Adial Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
STSS Stock Earnings: Sharps Technology Misses EPS for Q1 2024
STSS stock results show that Sharps Technology missed analyst estimates for earnings per share the first quarter of 2024.
BBLG Stock Earnings: Bone Biologics Beats EPS for Q1 2024
BBLG stock results show that Bone Biologics beat analyst estimates for earnings per share the first quarter of 2024.
BIVI Stock Earnings: BioVie Beats EPS for Q3 2024
BIVI stock results show that BioVie beat analyst estimates for earnings per share the third quarter of 2024.
PTN Stock Earnings: Palatin Techs Misses EPS for Q3 2024
PTN stock results show that Palatin Techs missed analyst estimates for earnings per share the third quarter of 2024.
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the first quarter of 2024.
PDSB Stock Earnings: PDS Biotechnology Beats EPS for Q1 2024
PDSB stock results show that PDS Biotechnology beat analyst estimates for earnings per share the first quarter of 2024.
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q1 2024
SGMT stock results show that Sagimet Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
SLDB Stock Earnings: Solid Biosciences Meets EPS for Q1 2024
SLDB stock results show that Solid Biosciences met analyst estimates for earnings per share the first quarter of 2024.
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q1 2024
ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
ASMB Stock Earnings: Assembly Biosciences Beats EPS for Q1 2024
ASMB stock results show that Assembly Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
PPTA Stock Earnings: Perpetua Resources Misses EPS for Q1 2024
PPTA stock results show that Perpetua Resources missed analyst estimates for earnings per share the first quarter of 2024.
RNXT Stock Earnings: RenovoRx Beats EPS for Q1 2024
RNXT stock results show that RenovoRx beat analyst estimates for earnings per share the first quarter of 2024.
IMMX Stock Earnings: Immix Biopharma Beats EPS for Q1 2024
IMMX stock results show that Immix Biopharma beat analyst estimates for earnings per share the first quarter of 2024.
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
FULC Stock Earnings: Fulcrum Therapeutics Beats EPS for Q1 2024
FULC stock results show that Fulcrum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
NPWR Stock Earnings: NET Power Beats EPS for Q1 2024
NPWR stock results show that NET Power beat analyst estimates for earnings per share the first quarter of 2024.
TERN Stock Earnings: Terns Pharma Beats EPS for Q1 2024
TERN stock results show that Terns Pharma beat analyst estimates for earnings per share the first quarter of 2024.
ARTL Stock Earnings: Artelo Biosciences Beats EPS for Q1 2024
ARTL stock results show that Artelo Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
BRNS Stock Earnings: Barinthus Biotherapeutics Beats EPS for Q1 2024
BRNS stock results show that Barinthus Biotherapeutics beat analyst estimates for earnings per share the first quarter of 2024.
COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024
COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the first quarter of 2024.
3 – 10 of 240 results
